Watch: How intellectual property rights are helping to beat Covid-19
Experts from the life science and research community explain the crucial role of intellectual property rights in developing new vaccines and therapeutics for Covid-19.
Geneva Network contribution to the EC’s Pharmaceutical Strategy Roadmap
Geneva Network and allied think tanks have written to the European Commission calling for innovation to be at the heart of its Pharmaceutical Strategy.
The innovation paradox: why complex drug research is not being rewarded
The patent system in the US and the EU is not rewarding complex research into treatments for a host of prevalent diseases and conditions, and reforms are going in the wrong direction, says Erika Lietzan of the University of Missouri School of Law.
Don’t Let Life Sciences Innovation Become Another Coronavirus Casualty
Traditional rivals within the life sciences industry have pledged to cooperate by sharing data, patent libraries, and, if necessary, manufacturing capacity.
Trio sharpen Saudi healthcare innovation
They say bullying scars for life, but for one Saudi medical specialist it was early inspiration for a ground-breaking innovation at the sharp end of cartilage reconstruction.
Why Pharmaceutical Follow-On Innovation Should Be Eligible For Patent Protection
Despite the important role of intellectual property rights in incentivizing innovation, the patenting of pharmaceutical innovation is frequently accused of impeding access to medicine.
Special Algorithms in Wearable Technology Can Warn of Potential Heart Attacks Before They Happen
This post is one of a series in the #Innovate4Health policy research initiative. For centuries, people have been fascinated with and assisted by wearable technology.
Saudi Inventors Show the Way to Economic Transformation Through Healthcare Innovation
In emerging economies, encouraging innovation in healthcare can improve the health of a nation’s people and its economy. Saudi Arabia recognized this fact when
Improving access to medicines to meet the SDGs
Improving access to medicines and quality healthcare remains a key area of action for the member states of the United Nations.